SPDR S&P Biotech (XBI) - Stock Price & Dividends

Exchange: USA Stocks • Country: USA • Currency: USD • Type: Etf • ISIN: US78464A8707 • Health

The SPDR® S&P Biotech ETF (NYSE ARCA:XBI) aims to mirror the performance of the S&P Biotechnology Select Industry Index through a sampling approach. This fund typically invests almost all, with a minimum of 80%, of its assets in the index's securities, which encompass the biotechnology sector within the S&P Total Market Index.

The index, reflecting the biotechnology industry within the broader S&P TMI, provides investors with an opportunity to gain exposure to this specific segment of the market. By primarily investing in holdings from this index, the fund offers a chance to participate in the potential growth and performance of the biotechnology industry.

For further information on the SPDR® S&P Biotech ETF (NYSE ARCA:XBI), including specific details on its performance, holdings, fees, and more, you can visit the official website at http://www.spdrs.com. The fund is based in the United States, providing investors with access to the biotechnology sector within a diversified investment portfolio.

AI improved, may contain errors or wrong assumptions

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for SPDR S&P Biotech (XBI) - Stock Price & Dividends

XBI ETF Overview

Market Cap in USD 6,624m
Category Health
TER 0.35%
IPO / Inception 2006-01-31

XBI ETF Ratings

Fundamental -
Dividend 5.08
Growth 5y -0.17
Rel. Performance vs Sector -0.62
Analysts -
Fair Price Total Ret. 90.98
Fair Price DCF -

XBI Dividends

Yield 12m 0.02%
Yield on Cost 5y 0.02%
Dividends CAGR 5y 32.44%
Payout Consistency 51.2%

XBI Growth Ratios

Growth 12m 22.20%
Growth Correlation 12m 10%
Growth Correlation 3m 61%
CAGR 5y 2.29%
CAGR / Mean Drawdown 0.08
Sharpe Ratio 12m 0.59
Alpha vs SP500 12m -10.24
Beta vs SP500 5y weekly 1.09
CAPM 8.25%
Average Daily Range 2m 2.64%
Regime Oscillator 97.77
Volatility GJR Garch 1y 31.57%
Price / SMA 50 12.59%
Price / SMA 200 24.79%
Current Volume 16735.8k
Average Volume 20d 11895.3k

External Links for XBI ETF

News
Wall Street JournalBenzingaYahoo Finance
Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of XBI stocks?
As of February 29, 2024, the stock is trading at USD 101.53 with a total of 16,735,800 shares traded.
Over the past week, the price has changed by +9.80%, over one month by +11.82%, over three months by +39.05% and over the past year by +23.64%.
Why is XBI stock down?
Check with which Index or Commodity XBI has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return XBI Return S&P 500
1 Month 11.82% 3.05%
3 Months 39.05% 11.73%
12 Months 23.64% 29.22%
What is the forecast for XBI stock price target?
According to ValueRays Forecast Model, XBI SPDR S&P Biotech will be worth about 101.7 in February 2025. The stock is currently trading at 101.53. This means that the stock has a potential upside of +0.14%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 101.7 0.1%